An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patientsREGIERER, A. C; WOLTERS, R; UFEN, M. -P et al.Annals of oncology. 2014, Vol 25, Num 3, pp 633-638, issn 0923-7534, 6 p.Article

A Prospective Evaluation of the Durability of Palliative Interventions for Patients With Metastatic Breast CancerMORROGH, Mary; MINER, Thomas J; PARK, Anna et al.Cancer. 2010, Vol 116, Num 14, pp 3338-3347, issn 0008-543X, 10 p.Article

Circulating tumor cells in metastatic inflammatory breast cancerMEGO, M; DE GIORGI, U; HSU, L et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1824-1828, issn 0923-7534, 5 p.Article

Should we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published dataTARTARONE, A; ROMANO, G; GALASSO, R et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 7, pp 525-530, issn 0268-3369, 6 p.Article

Metastatic breast cancer: are we treating the same patients as in the past?UFEN, M.-P; KÖHNE, C. H; WISCHNESWKY, M et al.Annals of oncology. 2014, Vol 25, Num 1, pp 95-100, issn 0923-7534, 6 p.Article

Third consensus on medical treatment of metastatic breast cancerBESLIJA, S; BONNETERRE, J; PETIT, T et al.Annals of oncology. 2009, Vol 20, Num 11, pp 1771-1785, issn 0923-7534, 15 p.Article

Changing Indications for Surgery in Patients With Stage IV Breast Cancer : A Current PerspectiveMORROGH, Mary; PARK, Anna; NORTON, Larry et al.Cancer. 2008, Vol 112, Num 7, pp 1445-1454, issn 0008-543X, 10 p.Article

Eribulin: A Novel Cytotoxic Chemotherapy AgentPRESTON, Jessica N; TRIVEDI, Meghana V.The Annals of pharmacotherapy. 2012, Vol 46, Num 6, pp 802-811, issn 1060-0280, 10 p.Article

Second consensus on medical treatment of metastatic breast cancerBESLIJA, S; BONNETERRE, J; MENARD, S et al.Annals of oncology. 2007, Vol 18, Num 2, pp 215-225, issn 0923-7534, 11 p.Article

Attitudes of patients with metastatic breast cancer toward research biopsiesSEAH, D. S; SCOTT, S. M; PEPPERCORN, J et al.Annals of oncology. 2013, Vol 24, Num 7, pp 1853-1859, issn 0923-7534, 7 p.Article

Clinicopathological differences between breast cancer in patients with primary metastatic disease and those without: A multicentre studyBARINOFF, J; HILS, R; HEITZ, F et al.European journal of cancer (1990). 2013, Vol 49, Num 2, pp 305-311, issn 0959-8049, 7 p.Article

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancerPEELERS, D. J. E; VAN DEN EYNDEN, G. G; DIRIX, L. Y et al.British journal of cancer. 2011, Vol 104, Num 9, pp 1472-1477, issn 0007-0920, 6 p.Article

Chemotherapy for breast cancer (Review)HASSAN, M. S. U; ANSARI, J; SPOONER, D et al.Oncology reports. 2010, Vol 24, Num 5, pp 1121-1131, issn 1021-335X, 11 p.Article

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancerCHIA, Stephen K; SPEERS, Caroline H; D'YACHKOVA, Yulia et al.Cancer. 2007, Vol 110, Num 5, pp 973-979, issn 0008-543X, 7 p.Article

Mitoxantrone Plus Vinorelbine in Pretreated Patients with Metastatic Breast CancerONYENADUM, A; GOGAS, H; FOUNTZILAS, G et al.Journal of chemotherapy. 2007, Vol 19, Num 5, pp 582-589, issn 1120-009X, 8 p.Article

Salvage chemotherapy for metastatic breast cancer : results of a phase II study with bendamustineREICHMANN, U; BOKEMEYER, C; WALLWIENER, D et al.Annals of oncology. 2007, Vol 18, Num 12, pp 1981-1984, issn 0923-7534, 4 p.Article

A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancerMODI, Shanu; SEIDMAN, Andrew D; HUDIS, Clifford A et al.Breast cancer research and treatment. 2005, Vol 90, Num 2, pp 157-163, issn 0167-6806, 7 p.Article

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancerYONEMORI, Kan; KATSUMATA, Noriyuki; FUJIWARA, Yasuhiro et al.Breast cancer research and treatment. 2005, Vol 89, Num 3, pp 237-241, issn 0167-6806, 5 p.Article

Epirubicin plus docetaxel in metastatic breast cancer: Escalating dose does not improve efficacy. A phase II studyFABI, Alessandra; PAPALDO, Paola; COGNETTI, Francesco et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1963-1967, issn 0250-7005, 5 p.Article

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patientsSANTINI, Daniele; VINCENZI, Bruno; ANTONIETTA SATOLLI, Maria et al.Oncology reports. 2011, Vol 25, Num 6, pp 1545-1548, issn 1021-335X, 4 p.Article

Treatment of the primary tumor in breast cancer patients with synchronous metastasesALI, D; LE SCODAN, R.Annals of oncology. 2011, Vol 22, Num 1, pp 9-16, issn 0923-7534, 8 p.Article

A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unitBRUNETTO, A. T; SARKER, D; PAPADATOS-PASTOS, D et al.British journal of cancer. 2010, Vol 103, Num 5, pp 607-612, issn 0007-0920, 6 p.Article

Psychotherapy and survival in cancer : The conflict between hope and evidenceCOYNE, James C; STEFANEK, Michael; PALMER, Steven C et al.Psychological bulletin. 2007, Vol 133, Num 3, pp 367-394, issn 0033-2909, 28 p.Article

Capecitabine-docetaxel combination treatmentMANDELBLAT, Julia; BASHIR, Tayyaba; BUDMAN, Daniel R et al.Expert review of anticancer therapy. 2006, Vol 6, Num 9, pp 1169-1178, issn 1473-7140, 10 p.Article

Antibody therapy for breast cancerWILLEMS, Amina; GAUGER, Katja; HENRICHS, Cordula et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1483-1489, issn 0250-7005, 7 p.Article